Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The mystery of missing heritability: Genetic interactions create phantom heritability.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
Copolymer 1 inhibits manifestations of graft rejection.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.
Vitamin D intake and incidence of multiple sclerosis.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
Ustekinumab.
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Dynamic imaging of individual remyelination profiles in multiple sclerosis.
Application of fullerenes in nanomedicine: an update.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.

Pages